New $100 million downtown Phoenix bioscience building in the works / Phoenix Business Journal
Wexford Science & Technology LLC is moving ahead on a new $100 million bioscience building in downtown Phoenix next door to an identical tower that’s now nearly 100% full after the National Institute of Diabetes and Digestive and Kidney Disease signed a lease to occupy the seventh floor in the existing 850 PBC building.
The momentum in Arizona’s bioscience and health care sectors is continuing to build, especially when it comes to Arizona bioscience construction and building. Like the sciences they support, these structures are the result of studies being conducted, long-term planning, and expert implementation.
ASU receives $39.8M federal grant to create microelectronics innovation hub / Phoenix Business Journal
Arizona State University has landed a $39.8 million federal grant to create a regional network for microelectronics education, research, and development in the Southwest. Read more: Arizona Science Center, National Taiwan Science Education Center to collaborate
WearTech Applied Research Center receives $1.8M to fund more projects / Phoenix Business Journal (AZ Inno)
The Phoenix-based WearTech Applied Research Center received $1.8 million from the Arizona Commerce Authority to support the commercialization of eight new wearable technology projects intended to reduce stress, detect brain injuries in athletes, improve early diagnosis of cognitive decline, and more.
Arizona Tech Investors to back dozens of companies as organization grows membership / Phoenix Business Journal (AZ Inno)
Arizona Tech Investors, a prominent angel investment group that supports health care technology and more, is growing its membership and poised to back dozens of companies in the coming year.
Dr. David Alberts, who died in July at the age of 83, assisted in creating the University of Arizona Cancer Center in 1976 a year after moving to Arizona. He later served as its director and developed the center’s Cancer Prevention and Control Program into one of the top programs in the United States.
University of Arizona Cancer Center researchers are studying an iron-targeting molecule that may lead to the development of new anticancer drugs.
This summer, the city of Phoenix sponsored a pavilion and hosted a reception at the BIO International Convention in Boston and are now working with 26 prospects, 70% of which are international companies.
September 25: Leading Women: Biotech and Beyond
September 26: 5th Annual Drug Discovery and Development Summit
September 27: 2023 AZBio Awards
September 28: AZAdvances Health Innovation Showcase
September 29: Voice of the Patient